S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
CVE:PDP

Pediapharm Stock Forecast, Price & News

C$0.30
+0.01 (+1.69 %)
(As of 12/18/2018)
Add
Compare
Today's Range
C$0.29
C$0.31
50-Day Range
C$0.30
C$0.30
52-Week Range
C$0.25
C$0.49
Volume26,000 shs
Average Volume100,369 shs
Market CapitalizationC$66.36 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PDP News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediapharm and its competitors with MarketBeat's FREE daily newsletter.


About Pediapharm

Pediapharm Inc. operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
C$11.16 million
Cash Flow
C$0.01 per share
Book Value
C($0.01) per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
C$66.36 million
Next Earnings Date
N/A
Optionable
Optionable

MarketRank

Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Pediapharm (CVE:PDP) Frequently Asked Questions

What stocks does MarketBeat like better than Pediapharm?

Wall Street analysts have given Pediapharm a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Pediapharm wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Is Pediapharm a good dividend stock?

Pediapharm pays an annual dividend of C$0.14 per share and currently has a dividend yield of 0.00%.

Who are Pediapharm's key executives?

Pediapharm's management team includes the following people:
  • Mr. Sylvain Chretien, Pres, CEO & Director (Age 54)
  • Mr. Roland Boivin, Chief Financial Officer
  • Mr. Richard Labelle, VP of Sales & Marketing
  • Mr. Benoît Hébert, VP of Bus. Devel. & Licensing (Age 50)
  • Mr. Normand Chartrand, Consultant (Age 59)

What other stocks do shareholders of Pediapharm own?

What is Pediapharm's stock symbol?

Pediapharm trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PDP."

How do I buy shares of Pediapharm?

Shares of PDP and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Pediapharm's stock price today?

One share of PDP stock can currently be purchased for approximately C$0.30.

How much money does Pediapharm make?

Pediapharm has a market capitalization of C$66.36 million and generates C$11.16 million in revenue each year.

What is Pediapharm's official website?

The official website for Pediapharm is www.pedia-pharm.com.

Where are Pediapharm's headquarters?

How can I contact Pediapharm?

Pediapharm's mailing address is 1 du Commerce Pl Suite 225, VERDUN, QC H3E 1A2, Canada. The company can be reached via phone at +1-514-7622626.


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.